We also observed that MBC patients with CTCs⩾5 have a doubled risk of VTE compared with patients with CTCs<5; however, this difference did not reach statistical significance.
← all excerpts
Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients.
1
—
—